Home/Filings/4/0001209191-09-054215
4//SEC Filing

Weidenbruch John 4

Accession 0001209191-09-054215

CIK 0001093649other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:42 PM ET

Size

5.6 KB

Accession

0001209191-09-054215

Insider Transaction Report

Form 4
Period: 2009-11-24
Weidenbruch John
Ex. VP, Gen. Counsel and Secr.
Transactions
  • Purchase

    Common Stock

    2009-11-24$1.89/sh+20,000$37,80035,000 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.92, inclusive. The reporting person undertakes to provide to Idenix Pharmaceuticals, any security holder of Idenix Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1
  • filerCIK 0001349877

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:42 PM ET
Size
5.6 KB